Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Leerink Partners 2015 Global Healthcare Conference being held February 11-12, 2015 at the Waldorf Astoria in New York City. The Company is scheduled to present on Wednesday, February 11 at 11:05am (ET) and will provide a corporate update on the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Portfolio (LFRP).
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
